MedTrace Logo

2D-speckle Tracking in Pediatric Renal Chronic Disease

NCT04897672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2022-01-11

No results posted yet for this study

Summary

The SPECKLE- KIDNEY-PED is a multicentre observational controlled trial aiming to evaluate the 2D-Speckle tracking in a population of 85 patients aged from 6 to 17 years old with a chronic renal disease and to compare the results to those of 85 age and gender-matched healthy subjects. The secondary objective is to assess the conventional echocardiographic parameters and the level of exercice capacity.

Conditions

  • Chronic Renal Disease
  • Chronic Renal Insufficiency
  • Congenital Heart Disease

Interventions

OTHER

Observational study

Observational study

Sponsors & Collaborators

  • University Hospital, Toulouse

    collaborator OTHER

  • University Hospital, Bordeaux

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • Marseille University Hospital- La Timone

    collaborator UNKNOWN

  • AP-HP - Hopital Robert Debré

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Pascal AMEDRO, MD-PhD · UH MONTPELLIER

  • Oscar WERNER, MD · UH MONTPELLIER

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-12-01
Completion
2021-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04897672 on ClinicalTrials.gov